A modelling approach to estimate the prevalence of treatment-resistant schizophrenia in the United States

por Mørup, Michael Frank, Kymes, Steven M., Oudin Åström, Daniel
Publicado 2020

Development and validation of a novel model for characterizing migraine outcomes within real-world data

por Hindiyeh, Nada A., Riskin, Daniel, Alexander, Kimberly, Cady, Roger, Kymes, Steven
Publicado 2022

Early clinical experience with eptinezumab: results of a retrospective observational study of patient response in the United States

por Starling, Amaal J., Kymes, Steven, Asher, Divya, Soni-Brahmbhatt, Seema, Karnik-Henry, Meghana
Publicado 2023

Using artificial intelligence to identify patients with migraine and associated symptoms and conditions within electronic health records

por Riskin, Daniel, Cady, Roger, Shroff, Anand, Hindiyeh, Nada A., Smith, Timothy, Kymes, Steven
Publicado 2023

Demonstration of an online tool to assist managed care formulary evidence-based decision making: meta-analysis of topical prostaglandin analog efficacy

por Kymes, Steven M, Burk, Caroline, Feinman, Todd, Williams, Julia M, Hollander, David A
Publicado 2011

Experiences, attitudes, and perceptions of caregivers of individuals with treatment-resistant schizophrenia: a qualitative study

por Brain, Cecilia, Kymes, Steven, DiBenedetti, Dana B., Brevig, Thomas, Velligan, Dawn I.
Publicado 2018

Who Would Pay Higher Taxes for Better Mental Health? Results of a Large‐Sample National Choice Experiment

por JOHNSON, F. REED, GONZALEZ, JUAN MARCOS, YANG, JUI‐CHEN, OZDEMIR, SEMRA, KYMES, STEVEN
Publicado 2021

Psychometric validation of a patient-reported single-item assessment of ‘Good Day Bad Day’ in a neurogenic orthostatic hypotension population treated with droxidopa

por François, Clément, Germain, Nicola, Majewska, Renata, Taieb, Vanessa, Hewitt, L. Arthur, Kymes, Steven
Publicado 2022

Characterization of the changes in supine blood pressure with long‐term use of droxidopa in patients with neurogenic orthostatic hypotension

por Hewitt, L. Arthur, Lindsten, Annika, Gorny, Stephen, Karnik‐Henry, Meghana, Kymes, Steven, Favit, Antonella
Publicado 2021

Comparison of indirect treatment methods in migraine prevention to address differences in mode of administration

por Fawsitt, Christopher G, Thom, Howard, Regnier, Stephane A, Lee, Xin Ying, Kymes, Steven, Vase, Lene
Publicado 2023

Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment

por Hauser, Robert A., Favit, Antonella, Hewitt, L. Arthur, Lindsten, Annika, Gorny, Stephen, Kymes, Steven, Isaacson, Stuart H.
Publicado 2022

Relationships between headache frequency, disability, and disability-related unemployment among adults with migraine

por Shapiro, Robert E, Martin, Ashley A, Bhardwaj, Shiven, Thomson, Heather, Maculaitis, Martine C, Anderson, Carlton, Kymes, Steven M
Publicado 2023

Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study

por Charleston, Larry, Talon, Brian, Sullivan, Christine, Anderson, Carlton, Kymes, Steven, Regnier, Stephane A., Soni-Brahmbhatt, Seema, Nahas, Stephanie J.
Publicado 2023

Six‐Month Use of Droxidopa for Neurogenic Orthostatic Hypotension

por François, Clément, Shibao, Cyndya A., Biaggioni, Italo, Duhig, Amy M., McLeod, Kim, Ogbonnaya, Augustina, Quillen, Apryl, Cannon, Joan, Padilla, Byron, Yue, Binglin, Orloski, Laurie, Kymes, Steven M.
Publicado 2019